Biomarker Technologies (China)

Recent papers from Biomarker Technologies (China)

1. First-line tislelizumab plus chemotherapy versus placebo plus chemotherapy in unresectable advanced/metastatic esophageal squamous cell carcinoma: minimum 3-year survival follow-up of a randomized phase 3 trial (RATIONALE-306)Nature Communications · 2026
2. Tislelizumab plus chemotherapy for advanced or metastatic esophageal squamous-cell carcinoma in patients with PD-L1 Tumor Area Positivity score ≥5%: a post hoc, exploratory, long-term follow-up of RATIONALE-306☆ESMO Open · 2026
3. Serum SERPINA3 as a Candidate Non-Invasive Biomarker for Neuromyelitis Optica Spectrum Disorder: Proteomic Discovery and Same-Center ValidationDiagnostics · 2026
4. A spatiotemporal atlas of giant-cell formation during Meloidogyne incognita infection in tomato rootsMolecular Horticulture · 2026
5. Complex filling histories for most conventional reservoirs revealed by quantitative diamondoid analysisAAPG Bulletin · 2026
6. Clinical benefit of PD-1 antibody plus chemotherapy in advanced HER2 negative gastric or gastro-oesophageal junction adenocarcinoma according to PD-L1 levels: Post-hoc analysis of RATIONALE-305 and pooled analysis of individual patient-level dataJournal of Hematology & Oncology · 2026
7. Automated risk scoring for venous thromboembolism using large language models with expert knowledge-augmented prompting: a multicenter validation studynpj Digital Medicine · 2026
8. Global Trends in Early-Onset Ischemic Heart Disease Linked to Obesity, 1990–2021: Insights from the Global Burden of Disease StudyJournal of Shanghai Jiaotong University (Science) · 2026
9. Quantitative Global Proteomics of Formalin-Fixed Paraffin-Embedded Tumors Identifies Dimethylated G3BP1 at Arginine 460 as a Robust Pharmacodynamic Biomarker of Methylthioadenosine Phosphorylase-Selective Protein Arginine Methyltransferase 5 InhibitionJournal of Proteome Research · 2026
10. Cunninghamia lanceolata genome illuminates the evolutionary dynamics of gymnospermsCell Reports · 2026
11. Intervening in aging and related diseases with gene therapy techniquesCell Reports Medicine · 2026
12. The entropic view of aging: from thermodynamics to biologyLife Medicine · 2026
13. Gray Matter Microstructure Measured Using Diffusion Imaging as a Biomarker of Severity in Lewy Body DiseasesMovement Disorders · 2026
14. Proteome of Bronchial Alveolar Lavage fluid and Serum from Tuberculosis patients during drug treatmentScientific Data · 2026
15. Association between adverse childhood experiences and cardiovascular disease risk in cardiovascular kidney metabolic syndrome stages 0 to 3.2026
16. Enhancement of Drying Performance of Biologic Paint Using Cellulose Nanocrystals and ChitosanCoatings · 2026
17. Restoring the FOXO1 geroprotective pathway via seno-resistant mesenchymal progenitor cells alleviates primate epididymal agingProtein & Cell · 2026
18. First-Line Tislelizumab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal CancerJAMA Oncology · 2026
19. Genome variations reveal rapid adaptation to domestication and habitat changes in the brown algae Saccharina japonicaJournal of Advanced Research · 2026
20. Abstract PS5-07-27: INAVO123: Phase 3 study of first-line inavolisib / placebo + a cyclin-dependent kinase 4/6 inhibitor + letrozole in participants with PIK3CA -mutated, hormone receptor-positive, HER2-negative, endocrine-sensitive advanced breast cancerClinical Cancer Research · 2026